首页> British journal of haematology> Risk factors and survival analysis of human leukocyte antigen loss in relapsed acute myeloid leukaemia/myelodysplastic syndrome patients after allogeneic haematopoietic stem cell transplantation.

Risk factors and survival analysis of human leukocyte antigen loss in relapsed acute myeloid leukaemia/myelodysplastic syndrome patients after allogeneic haematopoietic stem cell transplantation.

导出 LinkOut

翻译打印收藏纠错

第一作者： Tingting,Zhang

第一单位： National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.;Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.

作者： Tingting,Zhang ^[1] ; Yuqi,Zhang ^[1] ; Meijia,Zhou ^[2] ; Zhibo,Zhang ^[1] ; Xiebing,Bao ^[1] ; Lijun,Wen ^[1] ; Yufeng,Feng ^[1] ; Xiaobo,Li ^[3] ; Mingya,Zhai ^[3] ; Xiangjun,Liu ^[3] ; Zhao,Zeng ^[1] ; Xiaojin,Wu ^[1] ; Suning,Chen ^[1]

作者单位： National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.;Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. ^[1] Department of Hematology, Changshu Affiliated Hospital of Soochow University, Suzhou, China. ^[2] Beijing BoFuRui Gene Diagnostics Co., Ltd., Beijing, China. ^[3]

关键词 DLI HLA loss myeloablative allogeneic haematopoietic stem cell transplantation relapse second transplantation